Nathanial Brown compensation by year
Atea Pharmaceuticals Summary Compensation Table · the one fiscal year held| Component | FY2020 |
|---|---|
| Salary | $197,500 |
| Bonus | $57,000 |
| Stock awards | $0 |
| Option awards | $2,257,286 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $85,000 |
| Total | $2,596,784 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Atea Pharmaceuticals, Inc. DEF 14A filed April 29, 2021, accession 0001193125-21-140382, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Atea Pharmaceuticals, Inc. filed document, accession 0001193125-21-140382. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2021.
Atea Pharmaceuticals’s named executive officers, FY2020
as the company reported each| Named executive officer | Role | FY2020 total |
|---|---|---|
| Janet Hammond | Chief Development Officer | $4,030,318 |
| Jean-Pierre Sommadossi | President, Chief Executive Officer and Chairman of the Board | $2,886,987 |
| Nathanial Brown · this page | Former Chief Medical Officer | $2,596,784 |
| Maria Arantxa Horga | Chief Medical Officer | $2,149,064 |
| Andrea Corcoran | Chief Financial Officer, Executive Vice President, Legal | $1,488,000 |
The full Atea Pharmaceuticals compensation record
free company briefThis page is one person within Atea Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Atea Pharmaceuticals proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Atea Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.